T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis

J Thorac Oncol. 2017 Sep;12(9):e138-e139. doi: 10.1016/j.jtho.2017.04.022.

Authors

Hugo Gortais¹, Catherine Daniel¹, François-Clément Bidard¹, Emmanuelle Jeannot², Céline Callens², Luc Cabel³

Affiliations

¹ Department of Medical Oncology, Curie institute, Paris, France.
² Department of Genetics, Curie institute, Paris, France.
³ Department of Genetics, Curie institute, Paris, France. Electronic address: luc.cabel@curie.fr.

PMID: 28838712
DOI: 10.1016/j.jtho.2017.04.022

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acrylamides
Adult
Aniline Compounds
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
ErbB Receptors / genetics
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Meningeal Carcinomatosis / drug therapy*
Meningeal Carcinomatosis / pathology
Mutation
Piperazines / pharmacology
Piperazines / therapeutic use*

Substances

Acrylamides
Aniline Compounds
Antineoplastic Agents
Piperazines
osimertinib
EGFR protein, human
ErbB Receptors